Suppr超能文献

耐万古霉素粪肠球菌的体外药敏研究。

In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.

作者信息

Sahm D F, Kissinger J, Gilmore M S, Murray P R, Mulder R, Solliday J, Clarke B

机构信息

Clinical Microbiology Laboratory, University of Chicago, Illinois 60637-1463.

出版信息

Antimicrob Agents Chemother. 1989 Sep;33(9):1588-91. doi: 10.1128/AAC.33.9.1588.

Abstract

Vancomycin resistance exhibited by Enterococcus faecalis isolates V583, V586, and V587 is described. The vancomycin MICs ranged from 32 to 64 micrograms/ml. Although resistant to vancomycin, the isolates were susceptible to teicoplanin (MIC, less than or equal to 0.5 micrograms/ml). Such a glycopeptide susceptibility profile has not been previously described for E. faecalis. Time kill studies showed that vancomycin resistance adversely affected the synergistic activity that vancomycin and aminoglycoside combinations usually demonstrate against enterococci. However, the ability to detect vancomycin resistance varied with the susceptibility testing method used. Whereas broth microdilution, broth macrodilution, and agar dilution methods detected resistance, disk-agar diffusion and the AutoMicrobic system Gram-Positive GPS-A susceptibility card (Vitek Systems Inc., Hazelwood, Mo.) did not. To detect vancomycin resistance reliably and establish the incidence of such E. faecalis isolates, adjustments in some susceptibility testing methods may be necessary.

摘要

描述了粪肠球菌分离株V583、V586和V587所表现出的万古霉素耐药性。万古霉素的最低抑菌浓度(MIC)范围为32至64微克/毫升。尽管这些分离株对万古霉素耐药,但它们对替考拉宁敏感(MIC小于或等于0.5微克/毫升)。这种糖肽类药敏谱此前尚未在粪肠球菌中描述过。时间杀菌研究表明,万古霉素耐药性对万古霉素和氨基糖苷类药物联合通常表现出的针对肠球菌的协同活性有不利影响。然而,检测万古霉素耐药性的能力因所使用的药敏试验方法而异。肉汤微量稀释法、肉汤常量稀释法和琼脂稀释法能检测到耐药性,而纸片琼脂扩散法和自动微生物系统革兰氏阳性GPS - A药敏卡(Vitek系统公司,密苏里州黑兹尔伍德)则不能。为了可靠地检测万古霉素耐药性并确定此类粪肠球菌分离株的发生率,可能需要对一些药敏试验方法进行调整。

相似文献

1
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.
Antimicrob Agents Chemother. 1989 Sep;33(9):1588-91. doi: 10.1128/AAC.33.9.1588.
6
In vitro activity of the new glycopeptide decaplanin.
Eur J Clin Microbiol Infect Dis. 1992 May;11(5):458-62. doi: 10.1007/BF01961864.
8
In vitro detection of enterococcal vancomycin resistance.
Antimicrob Agents Chemother. 1990 Sep;34(9):1846-8. doi: 10.1128/AAC.34.9.1846.

引用本文的文献

1
Streptococcal natural products mediate interspecies competition with Gram-positive bacterial pathogens.
bioRxiv. 2025 Jul 31:2025.07.31.667707. doi: 10.1101/2025.07.31.667707.
2
Exploring the Potential of Phytocannabinoids Against Multidrug-Resistant Bacteria.
Plants (Basel). 2025 Jun 20;14(13):1901. doi: 10.3390/plants14131901.
3
Antimycobacterial activity of the plectasin derivative NZ2114.
Front Microbiol. 2025 Jun 26;16:1613241. doi: 10.3389/fmicb.2025.1613241. eCollection 2025.
4
Comparative and functional genomic analysis of foreign DNA defense mechanisms in .
Microbiol Spectr. 2025 Aug 5;13(8):e0028925. doi: 10.1128/spectrum.00289-25. Epub 2025 Jun 18.
5
The expanded immunoregulatory protease network in mosquitoes is governed by gene coexpression.
Proc Natl Acad Sci U S A. 2025 May 6;122(18):e2425863122. doi: 10.1073/pnas.2425863122. Epub 2025 Apr 30.
7
Genome-wide analysis of genes that facilitate interspecies competition with .
J Bacteriol. 2025 Mar 20;207(3):e0043824. doi: 10.1128/jb.00438-24. Epub 2025 Feb 4.
8
Dynamic collateral sensitivity profiles highlight opportunities and challenges for optimizing antibiotic treatments.
PLoS Biol. 2025 Jan 8;23(1):e3002970. doi: 10.1371/journal.pbio.3002970. eCollection 2025 Jan.
10
Enterococcal-host interactions in the gastrointestinal tract and beyond.
FEMS Microbes. 2024 Sep 9;5:xtae027. doi: 10.1093/femsmc/xtae027. eCollection 2024.

本文引用的文献

1
Synergy of penicillin and gentamicin against Enterococci.
J Infect Dis. 1971 Dec;124 Suppl:S207-9. doi: 10.1093/infdis/124.supplement_1.s207.
3
In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.
Antimicrob Agents Chemother. 1973 Oct;4(4):383-7. doi: 10.1128/AAC.4.4.383.
4
Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.
Antimicrob Agents Chemother. 1973 Aug;4(2):120-4. doi: 10.1128/AAC.4.2.120.
6
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.
Antimicrob Agents Chemother. 1985 Mar;27(3):357-62. doi: 10.1128/AAC.27.3.357.
7
Recovery of resistant enterococci during vancomycin prophylaxis.
J Clin Microbiol. 1988 Jun;26(6):1216-8. doi: 10.1128/jcm.26.6.1216-1218.1988.
8
High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.
J Clin Microbiol. 1988 Feb;26(2):257-60. doi: 10.1128/jcm.26.2.257-260.1988.
10
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.
Ann Intern Med. 1987 May;106(5):687-91. doi: 10.7326/0003-4819-106-5-687.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验